CD44 and prostate cancer: Previously, the same group had shown that MAO-A upregulation in prostate stromal fibroblasts promotes tumorigenesis via ROS generation and TWIST1-mediated paracrine IL-6/STAT3 signaling, responsible for increasing CD44 in prostate cancer cells which points to the maintenance of a de-differentiated phenotype.